Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,462.80
(
0.00%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
111.51
(
-0.77%
)
Bitcoin
76,009.56
(
0.31%
)
News Focus
News Focus
Post# of 257470
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

rogerm

Send PM Follow Ignore
Followers 2
Posts 112
Boards Moderated 0
Alias Born 08/04/2005

rogerm

Re: mcbio post# 208053

Tuesday, 01/17/2017 12:54:41 AM

Tuesday, January 17, 2017 12:54:41 AM

Post# of 257470
The best Alopecia Areata trial result was obtained with oral Ruxolitinib. ACRS appears to be far behind INCY which is running a P2 topical ruxolitinib and CNCE which has a P2 with a oral deuterated ruxolitinib. http://www.investorvillage.com/smbd.asp?mb=18114&mn=596&pt=msg&mid=16391346
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today